Novo Nordisk said the Food and Drug Administration approved the diabetes-drug Ozempic to be used to help kidney-disease patients. Ozempic, or semaglutide, can now be used to reduce the risk of ...

Novo Nordisk’s NVO shares gained 8.5% on Friday after the company announced positive top-line data from an early to mid-stage ...

NPA chairman Nick Kaye told the PA news agency that while obesity is "one of the biggest challenges facing" the UK, they are ...

An investigational drug from Veru helped preserve lean mass in patients taking Wegovy, though some experts raised questions ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

A new weight loss drug from Novo Nordisk helped patients lose a large amount of weight, providing a boost for Novo in the ...

New data obtained has found cases soared over the four weeks to the end of November, with an extra 118 hospitalisations ...

People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

Weight loss jabs such as Wegovy are “lifelong treatments” and most people who stop taking them will lose the effects, a scientist who developed the revolutionary drugs has said. Professor ...

The following information describes the dosage that’s commonly used or recommended. However, be sure to take the dosage your doctor prescribes for you. Starting Mounjaro dosage 2.5 mg once per ...

Wegovy comes as a liquid solution inside a prefilled single-dose pen for subcutaneous injection ... Save up to $19 per fill off of the retail price The retail price of Wegovy is $1349.